Sign in

CIK 0000842023 · Large accelerated filer

BIO-TECHNE Corp

Sign in to watch
Ticker
TECH
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
MN
Entity type
operating
EIN
411427402
Phone
612-379-8854
Business address
614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
Former names
TECHNE CORP /MN/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-08-07 Hippel James Chief Financial Officer Shares withheld for taxes −1,094 $180.14 $197K 4,382
2018-08-07 Hippel James Chief Financial Officer Option exercise · Restricted Stock Units −2,398 602
2018-08-07 Hippel James Chief Financial Officer Returned to the company · Restricted Stock Units −602 0
2018-08-07 Hippel James Chief Financial Officer Returned to the company · Stock Options (Right to buy) −3,762 14,988
2018-06-07 Kummeth Charles R. Chief Executive Officer Sale −8,000 $160.00 $1.3M 76,472
2018-05-04 Eansor Norman David SVP - Novus Biologicals Sale −1,136 $145.19 $165K 2,266
2018-05-01 Kelderman Kim President, Diagnostics & Genom Grant or award · Restricted Stock +5,000 5,000
2018-05-01 Kelderman Kim President, Diagnostics & Genom Grant or award · Stock Option (Right to Buy) +2,652 2,652
2018-05-01 Kelderman Kim President, Diagnostics & Genom Grant or award · Stock Option (Right to Buy) +7,348 10,000
2018-02-13 Dinarello Charles A Director Option exercise +5,000 $65.47 $327K 13,212
2018-02-13 Dinarello Charles A Director Sale −2,495 $135.76 $339K 10,717
2018-02-13 Dinarello Charles A Director Sale −2,505 $136.36 $342K 8,212
2018-02-13 Dinarello Charles A Director Option exercise · Stock Option (right to buy) −5,000 0
2017-11-01 BAUMGARTNER ROBERT V Director Option exercise +5,000 $63.03 $315K 12,712
2017-11-01 BAUMGARTNER ROBERT V Director Sale −5,000 $130.18 $651K 7,712
2017-11-01 BAUMGARTNER ROBERT V Director Option exercise · Stock Option (Right to buy) −5,000 0
2017-10-26 KEEGAN JOSEPH D Director Grant or award +739 739
2017-10-26 KEEGAN JOSEPH D Director Grant or award · Stock Options (Right to buy) +3,125 3,125
2017-10-26 Kummeth Charles R. Chief Executive Officer Grant or award +14,194 84,472
2017-10-26 Kummeth Charles R. Chief Executive Officer Grant or award · Restricted Stock Unit +21,291 21,291

Page 56 of 64 · 1,274 trades